---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-027293"
form_type: "8-K"
ticker: "CLRB"
cik: "0001279704"
company_name: "Cellectar Biosciences, Inc."
filed_at: "2022-02-25T23:59:59+00:00"
generated_at: "2026-06-27T04:04:04.676095+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cellectar Biosciences names Chad Kolean CFO, promotes Jarrod Longcor to COO

## Summary
- CFO Dov Elefant resigned Feb 22, 2022; Chad Kolean rejoined as CFO same day, previously served as CFO 2014-2017.
- Kolean receives $340K base salary, 40% target bonus, and 150,000-share option (3-yr vest) as inducement grant.
- Jarrod Longcor promoted to COO from Chief Business Officer; he has been with the company for 6 years.
- Option exercise price equals Feb 22, 2022 closing price; Kolean eligible for annual equity awards under 2021 plan.

## SEC filing metadata
- accession: 0001104659-22-027293
- form_type: 8-K
- ticker: CLRB
- cik: 0001279704
- company_name: Cellectar Biosciences, Inc.
- filed_at: 2022-02-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1279704/000110465922027293/0001104659-22-027293-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1279704/000110465922027293/tm227716d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-027293
- JSON: https://secwatch.observer/filing/0001104659-22-027293.json
- Plain text: https://secwatch.observer/filing/0001104659-22-027293.txt

## Key facts
- Executive change
  Jarrod Longcor changed role as Chief Operating Officer at Cellectar Biosciences, Inc..
  - Action: promoted
  - Role: Chief Operating Officer
  source text: On February 22, 2022, Jarrod Longcor, age 48, was promoted to the Company’s Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279704/000110465922027293/0001104659-22-027293-index.htm
- Executive change
  Dov Elefant resigned as Chief Financial Officer at Cellectar Biosciences, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On February 22, 2022, Dov Elefant, the Chief Financial Officer of Cellectar Biosciences, Inc. (the “Company”), resigned from his office effective February 22, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279704/000110465922027293/0001104659-22-027293-index.htm
- Executive change
  Chad Kolean was appointed as Chief Financial Officer at Cellectar Biosciences, Inc..
  - Action: rejoined
  - Role: Chief Financial Officer
  source text: On February 22, 2022, Chad Kolean, age 57, rejoined the Company as its Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279704/000110465922027293/0001104659-22-027293-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.